Sonia and Arthur Labatt Brain Tumor Research Centre, Hospital for Sick Children, University Avenue, Toronto, Ontario, Canada M5G 1X8.
Cancer Res. 2010 Oct 15;70(20):8199-210. doi: 10.1158/0008-5472.CAN-09-4562. Epub 2010 Sep 28.
Mechanisms by which c-Myc (Myc) amplification confers aggressive medulloblastoma phenotypes are poorly defined. Here, we show using orthotopic models that high Myc expression promotes cell migration/invasion and induces metastatic tumors, which recapitulate aggressive histologic features of Myc-amplified primary human medulloblastoma. Using ChIP-chip analysis, we identified cell migration and adhesion genes, including Tsp-1/THBS1, ING4, PVRL3, and PPAP2B, as Myc-bound loci in medulloblastoma cells. Expression of Tsp-1 was most consistently and robustly diminished in medulloblastoma cell lines and primary human tumors with high Myc expression (n = 101, P = 0.032). Strikingly, stable Tsp-1 expression significantly attenuated in vitro transformation and invasive/migratory properties of high Myc-expressing medulloblastoma cells without altering cell proliferation, whereas RNA interference-mediated Myc knockdown was consistently accompanied by increased Tsp-1 levels and reduced cell migration and invasion in medulloblastoma cells. Chromatin immunoprecipitation (ChIP) assays revealed colocalization of Myc and obligate partner Max and correlated diminished RNA polymerase II occupancy (∼3-fold decrease, P < 0.01) with increased Myc binding at a core Tsp-1 promoter. Reporter gene and/or gel shift assays confirmed direct repression of Tsp-1 transcription by Myc and also identified JPO2, a Myc interactor associated with metastatic medulloblastoma, as a cofactor in Myc-mediated Tsp-1 repression. These findings indicate the Myc-regulatory network targets Tsp-1 via multiple mechanisms in medulloblastoma transformation, and highlight a novel critical role for Tsp-1 in Myc-mediated aggressive medulloblastoma phenotypes.
c-Myc(Myc)扩增赋予神经母细胞瘤侵袭性表型的机制尚未完全明确。在这里,我们使用原位模型表明,高 Myc 表达促进细胞迁移/侵袭,并诱导转移性肿瘤,这些肿瘤再现了 Myc 扩增的原发性人类神经母细胞瘤的侵袭性组织学特征。通过 ChIP-chip 分析,我们鉴定了细胞迁移和黏附基因,包括 Tsp-1/THBS1、ING4、PVRL3 和 PPAP2B,作为神经母细胞瘤细胞中 Myc 结合的基因座。Tsp-1 的表达在具有高 Myc 表达的神经母细胞瘤细胞系和原发性人类肿瘤中最一致且显著减少(n=101,P=0.032)。引人注目的是,稳定表达 Tsp-1 显著减弱了高 Myc 表达的神经母细胞瘤细胞的体外转化和侵袭/迁移特性,而不改变细胞增殖,而 Myc 敲低的 RNA 干扰则始终伴随着 Tsp-1 水平的增加和神经母细胞瘤细胞迁移和侵袭的减少。染色质免疫沉淀(ChIP)分析显示 Myc 和必需伴侣 Max 的共定位,并与 RNA 聚合酶 II 占据减少(~3 倍,P<0.01)相关,导致核心 Tsp-1 启动子处 Myc 结合增加。报告基因和/或凝胶阻滞分析证实了 Myc 对 Tsp-1 转录的直接抑制,并且还鉴定了 JPO2,一种与转移性神经母细胞瘤相关的 Myc 相互作用蛋白,作为 Myc 介导的 Tsp-1 抑制的共因子。这些发现表明,Myc 调节网络通过多种机制靶向神经母细胞瘤转化中的 Tsp-1,并强调了 Tsp-1 在 Myc 介导的侵袭性神经母细胞瘤表型中的新的关键作用。